AIMS: Information of prognosis for patients with cutaneous melanoma is sparse and controversial. An understanding of the pattern of recurrence after melanoma’s surgical treatments is helpful in coordinating a rational plan of follow-up in these patients. METHODS: From January 1999 to December 2007, 300 consecutive patients with primary cutaneous malignant melanoma stage I or II (AJCC) were enrolled. Patients were divided into three groups according to Breslow thickness: < 1 mm (82 pts); between 1 and 4 mm (186 pts); > 4 mm (32 pts). All patients underwent regular follow-up with clinical examination, US, chest x-ray and PET. RESULT: The median follow-up time from the date of primary melanoma diagnosis was 60 months (range, 12 – 108 months). The rate of development of skin recurrence was respectively in the three groups 1.2 % (1 pts/82), 7.5 % (14pts/186) and 18.8 % (6pts/32). With regard to nodal recurrence rates were 1.2 % (1 pts/82), 2.7 % (5 pts/186), 9.3 % (3 pts/ 32) and the percentage of distant

FOLLOW-UP OF 300 MELANOMA PATIENTS SUBMITTED TO SENTINEL NODE BIOPSY

CARCOFORO, Paolo;SOLIANI, Giorgio;PORTINARI, Mattia;PALINI, Gian Marco;DE TROIA, Alessandro;PANAREO, Stefano;FEGGI, Luciano
2009

Abstract

AIMS: Information of prognosis for patients with cutaneous melanoma is sparse and controversial. An understanding of the pattern of recurrence after melanoma’s surgical treatments is helpful in coordinating a rational plan of follow-up in these patients. METHODS: From January 1999 to December 2007, 300 consecutive patients with primary cutaneous malignant melanoma stage I or II (AJCC) were enrolled. Patients were divided into three groups according to Breslow thickness: < 1 mm (82 pts); between 1 and 4 mm (186 pts); > 4 mm (32 pts). All patients underwent regular follow-up with clinical examination, US, chest x-ray and PET. RESULT: The median follow-up time from the date of primary melanoma diagnosis was 60 months (range, 12 – 108 months). The rate of development of skin recurrence was respectively in the three groups 1.2 % (1 pts/82), 7.5 % (14pts/186) and 18.8 % (6pts/32). With regard to nodal recurrence rates were 1.2 % (1 pts/82), 2.7 % (5 pts/186), 9.3 % (3 pts/ 32) and the percentage of distant
2009
melanoma; Follow-up; sentinel node
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11392/1401745
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact